A Novel Patient-Tailored, Cumulative Neurotechnology-Based Therapy for Upper-Limb Rehabilitation in Severely Impaired Chronic Stroke Patients: The AVANCER Study Protocol

Overview of attention for article published in Frontiers in Neurology, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 29 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 11,999 followers.

RT @UPHUMMEL_EPFL: Our paper describing the AVANCER clinical trial led by Claudia Bigoni is now out @FrontNeurol ! Discover the personalise…

16 Jul 2022

Reply Repost Favourite

Our paper describing the AVANCER clinical trial led by Claudia Bigoni is now out @FrontNeurol ! Discover the personalised neurotech-based therapy that we are delivering to stroke patients @EPFL in @CampusBiotech (Geneva) and in @CRR_Suva (Sion). https:/

15 Jul 2022

Reply Repost Favourite

New Research: A Novel Patient-Tailored, Cumulative Neurotechnology-Based Therapy for Upper-Limb Rehabilitation in Severely Impaired Chronic Stroke Patients: The AVANCER Study Protocol: Effective, patient-tailored rehabilitation to restore… https://t.co/plF

07 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.